Predictive Biomarkers Market Size, Share & Trends Analysis Report By Indication (Cancer, Neurological Disorder, Cardiovascular Disorder, Immunological Disorder, Others), By End-Use (Diagnostic Centers, Contract Research Organizations (CROs), Academic Research Institutes, Pharma & Biotech Companies, Others), By Region, And By Segment Forecasts, 2025-2034

Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Predictive Biomarkers Market Snapshot Chapter 4. Global Predictive Biomarkers Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Industry Analysis – Porter's Five Forces Analysis 4.7. COVID-19 Impact Analysis Chapter 5. Market Segmentation 1: By Indication Estimates & Trend Analysis 5.1. By Indication & Market Share, 2024-2034 5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Indication: 5.2.1. Cancer 5.2.2. Neurological Disorder 5.2.3. Cardiovascular Disorder 5.2.4. Immunological Disorder 5.2.5. Others Chapter 6. Market Segmentation 2: By End Use Estimates & Trend Analysis 6.1. By Indication & Market Share, 2024-2034 6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End Use: 6.2.1. Diagnostic Centers 6.2.2. Contract Research Organizations (CROs) 6.2.3. Academic Research Institutes 6.2.4. Pharma and Biotech companies 6.2.5. Others Chapter 7. Predictive Biomarkers Market Segmentation 3: Regional Estimates & Trend Analysis 7.1. North America 7.1.1. North America Predictive Biomarkers Market revenue (US$ Million) estimates and forecasts By Indication, 2021-2034 7.1.2. North America Predictive Biomarkers Market revenue (US$ Million) estimates and forecasts By End Use, 2021-2034 7.1.3. North America Predictive Biomarkers Market revenue (US$ Million) estimates and forecasts by country, 2021-2034 7.1.3.1. U.S. 7.1.3.2. Canada 7.2. Europe 7.2.1. Europe Predictive Biomarkers Market revenue (US$ Million) By Indication, 2021-2034 7.2.2. Europe Predictive Biomarkers Market revenue (US$ Million) By End Use, 2021-2034 7.2.3. Europe Predictive Biomarkers Market revenue (US$ Million) by country, 2021-2034 7.2.3.1. Germany 7.2.3.2. Poland 7.2.3.3. France 7.2.3.4. Italy 7.2.4. Spain 7.2.4.1. UK 7.2.4.2. Rest of Europe 7.3. Asia Pacific 7.3.1. Asia Pacific Predictive Biomarkers Market revenue (US$ Million) By Indication, 2021-2034 7.3.2. Asia Pacific Predictive Biomarkers Market revenue (US$ Million) By End Use, 2021-2034 7.3.3. Asia Pacific Predictive Biomarkers Market revenue (US$ Million) by country, 2021-2034 7.3.3.1. China 7.3.3.2. India 7.3.3.3. Japan 7.3.3.4. Australia 7.3.3.5. Rest of Asia Pacific 7.4. Latin America 7.4.1. Latin America Predictive Biomarkers Market revenue (US$ Million) By Indication, 2021-2034 7.4.2. Latin America Predictive Biomarkers Market revenue (US$ Million) By End Use, 2021-2034 7.4.3. Latin America Predictive Biomarkers Market revenue (US$ Million) by country, (US$ Million) 2021-2034 7.4.3.1. Brazil 7.4.3.2. Rest of Latin America 7.5. Middle East & Africa 7.5.1. Middle East & Africa Predictive Biomarkers Market revenue (US$ Million) By Indication, (US$ Million) 7.5.2. Middle East & Africa Predictive Biomarkers Market revenue (US$ Million) By End Use, (US$ Million) 7.5.3. Middle East & Africa Predictive Biomarkers Market revenue (US$ Million) by country, (US$ Million) 2021-2034 7.5.3.1. South Africa 7.5.3.2. GCC Countries 7.5.3.3. Rest of MEA Chapter 8. Competitive Landscape 8.1. Major Mergers and Acquisitions/Strategic Alliances 8.2. Company Profiles 8.2.1. Siemens Healthcare GmbH 8.2.2. F. Hoffman-La Roche Ltd 8.2.3. General Electric Company 8.2.4. Abbott 8.2.5. QIAGEN 8.2.6. Johnson & Johnson Services, Inc. 8.2.7. PerkinElmer Inc. 8.2.8. Thermo Fisher Scientific 8.2.9. Almac Group 8.2.10. Merck KGaA